15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis (Q40810593)

23 September 2017

title

15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis (English)

1 reference

23 September 2017

main subject

visceral leishmaniasis

1 reference

inferred from title

reactive oxygen species

1 reference

Preeti Vishwakarma

1

1 reference

23 September 2017

Naveen Parmar

2

1 reference

23 September 2017

Pawan Kumar Yadav

3

1 reference

23 September 2017

Pragya Chandrakar

4

1 reference

23 September 2017

Susanta Kar

5

1 reference

23 September 2017

publication date

1 February 2016

1 reference

Journal of Molecular Medicine

23 September 2017

published in

1 reference

23 September 2017

volume

94

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

695-710

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

23 September 2017

2 references

21 January 2018

12 December 2020

Leishmaniasis chemotherapy—challenges and opportunities

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Evolution from double to triple-antimalarial drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D2 and sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandins antagonistically control Bax activation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Effects of prostaglandin D2 on helper T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Role of interleukin-10 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive ox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Reactive Oxygen Species Production and Mitochondrial Dysfunction Contribute to Quercetin Induced Death in Leishmania amazonensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Combination therapy for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Delta(12)-prostaglandin J(2) is a potent inhibitor of influenza A virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Interleukin-10 and the pathogenesis of human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

In vitro and in vivo interactions between miltefosine and other antileishmanial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Recent developments in the synthesis of prostaglandins and analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Stereocontrolled organocatalytic synthesis of prostaglandin PGF2α in seven steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-016-1384-5

Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents

21 January 2018

1 reference

12 December 2020

Visceral leishmaniasis: experimental models for drug discovery

1 reference

12 December 2020

The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry

1 reference

12 December 2020

Total Synthesis of Prostaglandin 15d-PGJ2 and Investigation of its Effect on the Secretion of IL-6 and IL-12

1 reference

12 December 2020

Current trends in chemotherapy of tuberculosis.

1 reference

12 December 2020

Synergy, antagonism, and what the chequerboard puts between them

1 reference

12 December 2020

1 reference

12 December 2020

The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response

1 reference

12 December 2020

Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.

1 reference

12 December 2020

Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro

1 reference

12 December 2020

10.1007/S00109-016-1384-5

Identifiers

DOI

1 reference

23 September 2017

1 reference